Citation Impact
1 by Nobel laureates 55 standout
Citing Papers
Navigating the complexities of drug development for inflammatory bowel disease
2024 Standout
Enhancing in situ cancer vaccines using delivery technologies
2024 StandoutNobel
Works of Alar Irs being referenced
Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014
2016
Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis
2006
Author Peers
| Author | GHP | PHEOH | EE | Oncology | PRM | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| Alar Irs | 71 | 18 | 139 | 88 | 85 | 16 | 416 | |
| J.R. Pinto | 41 | 57 | 18 | 11 | 351 | |||
| Elisa Lloyd‐Smith | 171 | 464 | 8 | 20 | 29 | 34 | 1.0k | |
| Simona Cerritelli | 1 | 10 | 16 | 15 | 12 | 907 | ||
| Glen E. Bernhardt | 3 | 6 | 18 | 322 | ||||
| Dudy Lim | 1 | 4 | 454 |
All Works
Login with ORCID to disown or claim papers
Loading papers...